SWOG Cancer Research Network Clinical Trials Partnerships (SWOG CTP) is collaborating with AstraZeneca and Daiichi Sankyo as the scientific partners on their TROPION-Breast03 clinical trial. The study is open at sites across the United States, including numerous SWOG member sites, and in more than a dozen other countries. TROPION-Breast03 is a phase III, randomized, …
SWOG Clinical Trials Partnerships Announces Preferred Partnership Program’s First Collaboration SWOG Clinical Trials Partnerships (SWOG CTP) has signed a collaborative research agreement with Novartis Pharmaceuticals Corporation to form a strategic alliance via our Preferred Partnership Program that will jointly develop and conduct clinical trials investigating potential new cancer treatments. This relationship will carry out clinical …
SWOG Clinical Trials Partnerships (SWOG CTP) has taken major steps in establishing dedicated infrastructure for conducting non-federal trials with partners in industry by adopting a comprehensive e-research platform featuring new electronic data capture, integrated clinical trial management, and electronic trial master file systems. The e-research platform relies on Medidata RAVE for electronic data capture, paralleling …
SWOG Cancer Research Network and its charitable arm, The Hope Foundation for Cancer Research, have jointly developed a website for SWOG Clinical Trials Partnerships (SWOG CTP) as a public resource for current and potential partners to learn about SWOG CTP’s structure and staff, how it conducts research, its latest news, and how to get involved. …
